Ward MM and Adapt Analytics Announce a Partnership to Integrate AI and Machine Learning into Ward MM’s Clinical Decision Support Engine

Ward Medication Management (Ward MM) announces a collaboration with Adapt Analytics, to enhance the Ward MM clinical pharmacy decision support engine by leveraging Adapt Analytics expertise in artificial intelligence and machine learning.

The Ward MM decision support engine analyses real-time deidentified drug-drug and drug-genetic interaction records of aging Australians. Integrating AI and machine learning capabilities will enable Ward MM to provide our clinical pharmacists with a sophisticated medication recommendation tool as well as provide Ward MM with significant data mining capabilities.

Read More: Millennial Parents Feel More Secured about AI Babysitting their Generation Alpha Kids!

The collaboration with Adapt Analytics involves both Ward MM Australian and US teams.

“We are excited to be partnering with Adapt Analytics not only because of their expertise in the AI field but also because if their shared commitment with Ward MM to help eliminate medication related harm.  The implementation of the AI engines is another step in Ward MM’s growth as a precision medication management company,” says Dr Rocco Iannello, Global Head of Research at Ward MM.

Read More: UK and France to strengthen ties in Artificial Intelligence and data

Ward MM pharmacists will access the Ward MM decision support engine to enhance the medication prescribing advice they provide to GPs for the aging population.

“We feel fortunate for the opportunity to align with Ward MM’s vision where we’ll be able to apply our expertise and efforts toward the betterment of peoples’ lives,” says Mike Boyle, Partner at Adapt Analytics.

Read More: Insurtech: the new AI disruption is hitting insurance